Why Retail Investors Are Tracking Flight Centre Stock And Two Founder Led ASX Picks

Central banks in the US and Europe are keeping investors focused on the path of interest rates, which keeps short term market sentiment uncertain. Founder led companies from the Founder-Led Companies screener can look appealing when direction feels unclear, because leaders have their own reputations and capital on the line. This article highlights 3 stocks from that screener that showcase this legacy driven approach.

The three founder led stocks that follow are only a small sample, and the full screen surfaced 84 more companies with equally focused leadership stories that are not covered here. If you want to identify and analyze the highest conviction ideas that match your style, head straight to the Founder-Led Companies screener.

Flight Centre Travel Group (ASX:FLT)

Flight Centre Travel Group is a global travel retailer that arranges leisure and corporate trips, tours, hotels and related services under the Flight Centre and other brands across Australia, New Zealand, the Americas, Europe, the Middle East, Africa and Asia. Its revenue is mainly driven by leisure travel at about A$1.45b, corporate travel at about A$1.18b, with around A$239 million from its global head office segment. The company is a mid cap stock with a market value of about A$2.8b.

Flight Centre Travel Group stands out in the founder led screener because it mixes a large physical travel network with digital and AI tools such as its Sam assistant and Melon platform, plus a focus on higher margin corporate, luxury and cruise travel. Analysts are expecting a rebound in earnings, and the stock is flagged as trading at a discount to an estimated fair value, yet there are still questions around modest revenue growth, funding risk from reliance on external borrowing and an unstable dividend history. The new A$200 million buyback, fresh partnerships in AI powered travel and an experienced but long serving board all provide reasons for a more detailed look at the potential risk and return profile of Flight Centre from here.

Flight Centre’s mix of AI powered tools, higher margin travel and a fresh A$200 million buyback could be masking an even sharper risk and reward trade off. Get the full story in the analysis report for Flight Centre Travel Group

Build your own founder-led shortlist like Flight Centre Travel Group

Flight Centre Travel Group and the other two stocks in this article all came from a single screener, but the real edge comes when you tailor the filters yourself. Use our flexible Screener to mix valuation, growth, balance sheet and risk filters, or start with any of our curated Investing Ideas.

Macquarie Technology Group (ASX:MAQ)

Macquarie Technology Group is an Australian provider of telecom, cloud, cybersecurity and data centre services to corporate and government customers, with all of its A$379.4 million revenue coming from within Australia. Its largest segment is Cloud Services & Government at about A$223.9 million, followed by Telecom at about A$108.2 million and Data Centres at about A$83.6 million, partly offset by inter segment eliminations. The stock is a mid cap with a market value of roughly A$1.6b.

Macquarie Technology Group operates at the intersection of data centres, cloud and cybersecurity for Australian enterprises. Analysts attribute their expectations for earnings and revenue to this positioning, despite a recent dip in profit margins. The trade off is a relatively high P/E multiple and a balance sheet that relies entirely on external borrowing, so investors are paying a premium and taking on funding risk in line with that profile. For those seeking founder led exposure to digital infrastructure with a long operating history and experienced governance, the relationship between its valuation, non cash earnings and business profile may warrant closer examination.

Macquarie Technology Group sits where cloud, cybersecurity and data centres meet, yet the real story is how its premium P/E and fully debt funded balance sheet fit together. See how that trade off stacks up in the 2 key rewards and 1 important major warning sign

Mesoblast (ASX:MSB)

Mesoblast develops regenerative medicine therapies based on mesenchymal lineage cells for severe inflammatory and cardiovascular diseases across markets including Australia, the United States, Singapore and Switzerland. The company currently generates about US$65 million in revenue from developing its cell technology platform for commercialization and has partnered with large pharma groups to advance products in conditions such as chronic heart failure, chronic low back pain and pediatric graft versus host disease. Mesoblast is a mid cap stock with a market value of about A$3.1b.

Mesoblast is the kind of high risk, high potential story that often stands out in a founder led screener. It has a first in class cell therapy in Ryoncil with growing real world sales, a pipeline aimed at large markets such as chronic low back pain and heart failure, and analysts modelling rapid revenue and earnings growth from a low base. Set against that are ongoing losses, a high P/S multiple and fresh debt that underline how dependent the company still is on trial outcomes, regulatory decisions and payer support. For investors comfortable with volatility who want exposure to cell therapy as it matures, the balance between that potential and the associated funding and execution risks may merit closer attention.

Mesoblast’s pipeline story and early revenue can make the growth case look straightforward, yet the real inflection may sit with how analysts frame the analyst forecasts for Mesoblast

Seeking Fresh Alternatives Before They Fly

Some stocks can shift from quiet to breakout momentum faster than headlines catch up. Use these fresh idea lists before the crowd catches on and consider your options promptly.

• Spot cash generative companies that still look overlooked by the market with our curated 9 high quality undervalued stocks while the pricing gap is still open.
• Target businesses that are changing how automation and hardware work together through the hand picked 37 robotics and automation stocks before attention and liquidity increase.
• Consider positioning ahead of potential demand shifts in grid upgrades with a focused 37 power grid technology and infrastructure stocks while these infrastructure plays may still be under the radar.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com